Friday, June 19, 2009

A Study of 1592U89 in HIV-Infected Adults

Condition:   HIV Infections
Intervention:   Drug: Abacavir sulfate
Sponsor:   Glaxo Wellcome
Completed - verified December 1998 Read On Here.....

Condition:   HIV Infections
Intervention:  
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified April 1999 Read On Here.....

The body may hold a secret to normalizing skin cell growth that is over zealous in psoriasis and non-melanoma skin cancers and too slow in aging and sun-damaged skin, researchers say. Read On Here.....

Psoriasis is a chronic skin disease that affects approximately 2--3% of individuals in the Western world. New data have indicated that a subset of immune cells known as Tregs (which act to prevent other immune cells from responding inappropriately) are dysfunctional in a mouse model of psoriasis and that this dysfunction contributes substantially to the development of disease. Read On Here.....

Condition:   Osteoporosis
Interventions:   Drug: Human parathyroid hormone [hPTH-(1-34)];   Drug: alendronate
Sponsor:   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Completed - verified November 2008 Read On Here.....

Condition:   HIV Infections
Intervention:   Drug: Abacavir sulfate
Sponsor:   Glaxo Wellcome
Completed - verified December 1998 Read On Here.....

Condition:   HIV Infections
Intervention:  
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified April 1999 Read On Here.....

The body may hold a secret to normalizing skin cell growth that is over zealous in psoriasis and non-melanoma skin cancers and too slow in aging and sun-damaged skin, researchers say. Read On Here.....

Psoriasis is a chronic skin disease that affects approximately 2--3% of individuals in the Western world. New data have indicated that a subset of immune cells known as Tregs (which act to prevent other immune cells from responding inappropriately) are dysfunctional in a mouse model of psoriasis and that this dysfunction contributes substantially to the development of disease. Read On Here.....

Condition:   Osteoporosis
Interventions:   Drug: Human parathyroid hormone [hPTH-(1-34)];   Drug: alendronate
Sponsor:   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Completed - verified November 2008 Read On Here.....

Wednesday, June 17, 2009

11

1
1